key: cord-1051457-v8ek8ivv
authors: Unnarsdóttir, Anna Bára; Lovik, Anikó; Fawns-Ritchie, Chloe; Ask, Helga; Kõiv, Kadri; Hagen, Kristen; Didriksen, Maria; Christoffersen, Lea Arregui Nordahl; Garðarsson, Alexander Berg; McIntosh, Andrew; Kähler, Anna K; Campbell, Archie; Hauksdóttir, Arna; Erikstrup, Christian; Mikkelsen, Dorte Helenius; Altschul, Drew; Thordardottir, Edda Bjork; Frans, Emma Maria; Kvale, Gerd; Tómasson, Gunnar; Kariis, Hanna Maria; Jónsdóttir, Harpa Lind; Rúnarsdóttir, Harpa; Magnúsdóttir, Ingibjörg; Eid, Jarle; Jakobsdóttir, Jóhanna; Nielsen, Kaspar René; Kaspersen, Kathrine Agergård; Milani, Lili; Trogstad, Lill-Iren Schou; Yi, Lu; Bruun, Mie Topholm; Sullivan, Patrick F; Magnus, Per Minor; Shen, Qing; Nesvåg, Ragnar; Brandlistuen, Ragnhild E; Mägi, Reedik; Ostrowski, Sisse Rye; Løkhammer, Solveig; Solem, Stian; Reichborn-Kjennerud, Ted; Hansen, Thomas Folkmann; Werge, Thomas; Aspelund, Thor; Porteous, David J; Fang, Fang; Lehto, Kelli; Andreassen, Ole A; Pedersen, Ole Birger Vesterager; Hellard, Stephanie Le; Valdimarsdóttir, Unnur A
title: Cohort Profile: COVIDMENT: COVID-19 cohorts on mental health across six nations
date: 2021-11-20
journal: Int J Epidemiol
DOI: 10.1093/ije/dyab234
sha: 5b778ecbc3026bd1e8281c4ed430c35da0263db7
doc_id: 1051457
cord_uid: v8ek8ivv

nan

of COVID-19 and emphasized the need for multinational research in this area, 1,2 which additionally provides new insights into disease mechanisms. 2 Although a substantial number of studies on the mental health effects of COVID-19 has been published, the existing literature is largely limited by relatively small studies of convenience samples without pre-pandemic data, longitudinal data or cross-national comparisons. 3, 4 Some, 5, 6 but not all 7, 8 studies have reported evidence for a negative impact on mental health in the general adult population, including a rise in prevalence of symptoms of anxiety 9 and depression 10, 11 during the COVID-19 pandemic. Previous history of psychiatric problems, 12 higher age 13 and female sex 14 have been suggested as risk factors for mental health problems during the COVID-19 pandemic, although the weight of these factors is bound to vary over time and geographical areas and largely depends on the severity of outbreaks. Furthermore, COVID-19-mandated restrictions, such as quarantine measures, complete or partial lockdown and isolation, have been associated with deterioration in mental health [15] [16] [17] and so has dissatisfaction with governmental pandemic mitigations. 18 The severity of the pandemic and mitigating strategies has varied considerably across countries. For example, as of 31 August 2021, the cumulative number of deaths due to COVID-19 stands at 1940 per one million inhabitants in the UK, 1440 in Sweden, 973 in Estonia, 444 in Denmark, 149 in Norway and 96 in Iceland (Worldometers, 2021) . The variation in national pandemic response efforts and actual disease burden have implications for the proportion of citizens with first-hand exposure to COVID-19. Furthermore, mitigation responses may also affect health behaviours, social interactions, sense of security and trust in authorities, with potential downstream impact on population mental health. A key objective of the COVIDMENT initiative is to investigate whether differences in disease burden and mitigating responses to COVID-19 across countries (displayed in Figure 1 ) impact on psychiatric symptoms and disorders.

Due to the relatively narrow time window since the start of the pandemic, the long-term mental health consequences in exposed populations during the COVID-19 pandemic (i.e. patients, loved ones and front-line workers), as well as among those suffering unemployment or income losses, have not yet been sufficiently explored. Although research is still limited to small studies with short followup period, high prevalence of post-traumatic stress disorder (PTSD) 19, 20 and other mental health symptoms, 21 along with elevated rates of diagnosed psychiatric disorders, have been observed during the first weeks after hospital discharge of COVID-19 inpatients. 22 For how long such adverse mental health effects remain after recovery from COVID-19 is yet to be investigated. Moreover, considerable mental health impact has been noted among family members of COVID-19 patients, 3 with as yet unknown long-term consequences. Taken together, well-designed studies with long-term follow-up of COVID-19 patients, their loved ones and other high-risk groups are imperative for a comprehensive understanding of the mental health impact of the pandemic. 1 Based on the extensive research experience and existing infrastructures within the CoMorMent collaboration (an ongoing Horizon2020 programme on psychiatric and cardiometabolic comorbidities), we set out to establish new cohorts focusing on mental health indicators across six European nations during the pandemic. Funded by NordForsk (project No. 105668), the overarching aim of the COVIDMENT collaboration is to significantly advance current knowledge of long-term mental morbidity trajectories in the COVID-19 pandemic, both in the general population and in the specific risk groups.

A total of 392 817 individuals have now been recruited to the cohorts and the timeline of each data collection is shown in Figure 1 . Background characteristics of all cohorts with currently available data for analysis (N ¼ 389 925) are shown in Table 1 and the main sociodemographic characteristics of responders compared with the total population of each nation are shown in Supplementary  Table S1 , available as Supplementary data at IJE online. The design and recruitment process of each cohort are described below.

DBDS is an ongoing national cohort study currently comprising about 120 000 blood donors 23 with about 95% participation rate among invited blood donors. 24 All participants answer a health-related questionnaire and provide a blood sample for research purposes. Prospective assessment of long-term health changes related to COVID-19 has been obtained thrice through the governmental, personal, password-protected e-mail-system e-boks. 25 The first wave of the COVID-19 questionnaire was sent out in May 2020 (participation rate 63.5%), the second was sent out in October 2020 (participation rate 63.7%) and the third was sent ultimo May 2021 and is still ongoing (medio August 2021). A total of 71 562 participants have answered at least one of the COVID-19 questionnaires, and among active DBDS blood donors, approximately 87 700 had been tested for SARS-CoV-2 antibodies by April 2021.

Participants lost to follow-up were slightly younger and less educated compared with those who remained in the cohort. Compared with the Danish national population above 18 years of age, the DBDS slightly over-sampled men, individuals of higher age (70þ years) and highly educated individuals. Written informed consents were collected from all participants. The study was funded by the Danish regions and the Independent Research Fund Denmark (0214-00127B).

EstBB is a population-based cohort (N ¼ 200 000) with genotype and a rich variety of phenotypic and healthrelated information. 26 At recruitment, participants signed a broad consent form allowing follow-up linkage of their electronic health records (EHR) and contact for future studies, thereby providing a longitudinal collection of their phenotypic information. A COVID-19-related data The Norwegian BRY.DEG2020

BRY.DEG2020 (TAKE.CARE2020) is a longitudinal survey study established in March 2020 at the University of Bergen and Haukeland University Hospital, with the overarching aim to monitor the effect of the pandemic and its restrictions on mental health, using self-report data. Participants were recruited via social media and e-mail lists for universities across Norway and from patient organizations. Participants aged 18 years and older signed an informed consent before answering the survey. The first study wave was sent out in April 2020 (N ¼ 19 343, of whom 13 500 agreed to be recontacted), the second in December 2020 (N ¼ 6320) and the third is planned in October 2022. 27 Compared with the general Norwegian population, women and young individuals with higher education are ove-rrepresented in BRY.DEG2020. The group lost to follow-up differed from those remaining by having a lower age (mean age 30.6 vs 34.7 years), more men, more students and fewer with a completed bachelor's degree. The project was funded by the University of Bergen and Helse Bergen.

MoBa is a population-based pregnancy cohort study conducted by the Norwegian Institute of Public Health. 28 Pregnant women attending a routine ultrasound examination were invited and recruited from all over Norway in 1999 Norway in -2008 

The Scottish Generation Scotland study (GS) 30 

With Table 2 ). In addition, participants in each cohort answered extensive questionnaires on general health and working and life conditions during COVID-19, as well as questions on COVID-19-specific factors, such as COVID-19 symptoms, SARS-CoV-2 infection status and hospitalization (see Supplementary Table S2, available as  Table 2 Validated mental health instruments in the COVIDMENT cohorts, including register data Supplementary data at IJE online, for a detailed overview of measures). Pre-COVID mental health data are available for participants of all cohorts through self-reports or record linkage to population registers. Most cohorts are linked to national health registries, with lifelong data on mental disorders and comorbid diseases including pre-COVID conditions and long-term post-COVID outcomes. Several cohorts also include biobanks that will be used to study genetic and biological risk factors.

What has it found? Key findings Table 1 shows the sociodemographic characteristics of the COVIDMENT cohorts. Most of the cohorts had higher levels of female participation (57.7-81.5%), except the Danish DBDS with 50.7% males. The mean age of cohort participants ranged from 44.1 years (Estonian EstBB-C19) to 58.5 years (Danish DBDS) and the majority were in a relationship (60. 5-76.4% ). An exception is the Norwegian BRY.DEG2020 where the mean age was 31.8 years and 56.7% of participants were single. The highest educational level varied between cohorts, e.g. university education or higher was reported by 89.2% in the Danish DBDS and 47.1% in the Scottish CovidLife.

In terms of health-related risk factors, the highest prevalence of obesity was observed in the Icelandic C-19 Resilience (30.1%) and the lowest prevalence was observed in the Swedish Omtanke2020 (13.3%). The highest prevalence of current smoking was in the Norwegian BRY.DEG2020 (19.1%) and the lowest in the Norwegian MoBa (6.3%). The proportion with chronic somatic diseases (e.g. hypertension, lung disease) varied considerably across cohorts, ranging from 15.1% in the Norwegian MoBa to 48.7% in the Danish DBDS. The highest proportion of participants infected with SARS-CoV-2 was in the Estonian EstBB-C19 (25.2%) and the Norwegian BRY.DEG2020 (13.8%). The corresponding proportion was 10.1% in the Scottish CovidLife, 8.4% in the Swedish Omtanke2020, 4.3% in the Danish DBDS, 4.1% in the Icelandic C-19 Resilience and 1.2% in the Norwegian MoBa. Table 3 shows the prevalence of depressive symptoms above cut-off (measured as !10 on PHQ-9/>11 on EST-Q2) across cohorts adjusted for or stratified by age and sex. The overall prevalence of reporting depressive symptoms above cut-off ranged from 4.2% to 20.8% across the cohorts, namely 20.8% in Scottish CovidLife, 17.1% in Norwegian BRY.DEG2020, 17.1% in Swedish Omtanke2020, 16.6% in Icelandic C-19 Resilience, 15.0% in Estonian EstBB-C19, 7.6% in Danish DBDS and 4.2% in Norwegian MoBa. Across all cohorts, the average prevalence of depressive symptoms was 12.7% (95% CI: 8.0-19.8%) after adjusting for age, sex and season. The highest prevalence of depressive symptoms was consistently noted among young adults, i.e. 18-29 years of age, declining sharply thereafter in a stepwise fashion. Similarly, the prevalence of depressive symptoms was higher among females (5.0-24.4%) than males (3.5-17.7%) after adjusting for age. Figure 2 shows the prevalence of depressive symptoms above cut-off for all cohorts (excluding COVID-19 cases) by nationwide incidence of weekly COVID-19 cases per 100 000 persons during the 2 preceding weeks before responding to the PHQ-9/EST-Q2. We used a generalized additive mixed model to fit a multi-level model to the data, with a random effect for each study to account for correlations in the data within each study. The association between the prevalence of depressive symptoms with COVID-19 incidence was modelled using penalized regression spline for week (Supplementary Figure S1 , available as Supplementary data at IJE online). The distribution of the outcome was assumed quasi-binomial and each observation was weighted with the accompanying sample size. The adjustment for season was made by using a penalized spline for week (Supplementary Figure S2 , available as Supplementary data at IJE online). Trends varied across countries (Supplementary  Table S3 , available as Supplementary data at IJE online) but overall we found the association to be non-linear. The prevalence of depressive symptoms was highest at 14.3% (95% CI: 9.4-21.8%) when the COVID-19 incidence was around 30 weekly cases per 100 000 persons. This represents 61.0% (95% CI: 34.0-94.1%) higher prevalence of depressive symptoms than the prevalence, 8.9% (95% CI: 5.6-13.6%), at a COVID-19 incidence of 0 weekly cases per 100 000 persons. When the COVID-19 incidence was 60 weekly cases per 100 000 persons, the prevalence of depressive symptoms was 12.4% (95% CI: 7.9-19.4%), close to the average prevalence (Supplementary Figure S3 , available as Supplementary data at IJE online). Combined, these results suggest some influence of weekly COVID-19 incidence on population depressive symptoms primarily at the lower range of incidence rates, possibly reflecting early rise or the end of an epidemic wave.

The COVIDMENT project is a large-scale multinational collaboration between Denmark, Estonia, Iceland, Norway, Scotland and Sweden, which was established to significantly advance current knowledge of mental morbidity trajectories during and beyond the COVID-19 pandemic, by using ongoing semi-harmonized batteries of validated mental health assessments with longitudinal follow-up of 392 817 individuals, as well as large, data-rich record linkages to the national health registry resources. These resources are well powered for a systematic exploration of trans-national heterogeneity in pandemic effects, including how variations in mitigating responses to COVID-19 pandemic and disease burden across countries impact on psychiatric symptoms and disorders, both in exposed populations and on a population level. A weakness of the COVIDMENT project is that different strategies were used for recruitment to the various cohorts. Some cohorts, for example MoBa, EstBB-C19 and DBDS, consist of already established cohorts, some perhaps with over-representation of healthy individuals (e.g. blood donors and parents). Other cohorts, such as Omtanke2020, BRY.DEG2020 and C-19 Resilience, sent invitations to existing cohort members but also opened for volunteering participants through social media, which may have resulted in selection bias. Indeed, compared with the general populations, most of the cohorts include an over-representation of women as well as individuals of older age and higher education. [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] Recruitment differences may to some extent explain the differences in prevalence of depressive symptoms above cut-off across cohorts. Yet, prevalence differences in depressive disorders have been observed across European countries using similar recruitment. 47 Also, some cohorts targeted invitations to individuals diagnosed with SARS-CoV-2 or tested for SARS-CoV-2 with an RT-PCR test (i.e. C-19 Resilience and EstBB-C19), whereas other cohorts did not. The different recruitment strategies across cohorts may to some extent explain the higher levels of depressive symptoms when tested individuals are targeted for inclusion. Second, the cohorts rely on self-reported questionnaire data with associated risks of measurement errors. However, this risk is mitigated by also obtaining data on clinical diagnoses of psychiatric disorders from the population registers, which is a distinctive feature of the participating cohorts and countries.

Can I get hold of the data? Where can I find out more?

The individual-level data underlying this article were subject to ethical approval and cannot be shared publicly due to data protection laws in each participating country. The data can be shared on reasonable request to the corresponding author. We encourage scientists who are interested in collaboration with the COVIDMENT project to contact investigators via the study website [www.covid ment.is] or reach out to the principal investigator of the project. Prof. Valdimarsdó ttir [unnurav@hi.is], for further information.

The DBDS was approved by the Zealand and Central Denmark Regional Committees on Health Research Ethics (SJ-740 and M-2009237) and the Data Protection Agency (P-2019-99). The EstBB-C19 and EstBB-MHDC were approved by the Estonian Committee on Bioethics and Human Research (1.1-12/1277 and 1.1-12/2860). The C-19 Resilience was approved by the National Figure 2 National COVID-19 incidence and depressive symptoms across cohorts. The COVID-19 incidence is defined as the average number of confirmed cases per week per 100 000 persons in the 2 weeks prior to participants' response to the PHQ-9/EST-Q2 (COVID-19 cases excluded). Dotted black line represents trend with 95% confidence interval (blue area) Bioethics Committee (NBC no. 20-073, 21-071) as well as the National Data Protection Authority. The BRY.DEG2020 was approved by the Regional Committees for Medical and Health Research Ethics (123324). The MoBa was approved by the Regional Committees for Medical and Health Research Ethics (127708/14140/20138); this also includes approval to link the MoBa data with data from national health registries (including psychiatric and COVID-19 diagnostic information). The GS was approved by the East of Scotland Research Ethics Service (EoSRES). The Omtanke2020 ethical approval no. is 2020-01785.

Keep mental health in mind

Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic

COVID-19 pandemic and mental health consequences: systematic review of the current evidence

Longitudinal changes in mental health and the COVID-19 pandemic: evidence from the UK Household Longitudinal Study

Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population

Prevalence of mental disorders, suicidal ideation and suicides in the general population before and during the COVID-19 pandemic in Norway: a population-based repeated cross-sectional analysis

Anxiety and depression symptoms, the recovery from symptoms, and loneliness before and after the COVID-19 outbreak among the general population: findings from a Dutch population-based longitudinal study

Mental health before and during the COVID-19 pandemic in two longitudinal UK population cohorts

Ló pez-Antó n R, Santabá rbara J. Prevalence of depression during the COVID-19 outbreak: a meta-analysis of community-based studies

Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic

Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry

Impact of COVID-19 in the mental health in elderly: psychological and biological updates

The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public -a systematic review and metaanalysis

Loneliness, physical activity, and mental health during COVID-19: a longitudinal analysis of depression and anxiety in adults over the age of 50 between

COVID-19 related depression and anxiety among quarantined respondents

Prevalence of mental health problems during the COVID-19 pandemic: a systematic review and metaanalysis

Perceived efficacy of COVID-19 restrictions, reactions and their impact on mental health during the early phase of the outbreak in six countries

Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China

The differential psychological distress of populations affected by the COVID-19 pandemic

COVID-19 BioB Outpatient Clinic Study group. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors

Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA

The Danish Blood Donor Study: a large, prospective cohort and biobank for medical research

Digital questionnaire platform in the Danish blood donor study

Impact of COVID-19 Pandemic on sleep quality, stress level and health-related quality of life-a large prospective cohort study on adult Danes

Cohort Profile: Estonian Biobank of the Estonian Genome Center

Cohort Profile Update: The Norwegian Mother and Child Cohort Study (MoBa)

Self-selection and bias in a large prospective pregnancy cohort in Norway

Profile: Generation Scotland: Scottish Family Health Study (GS: SFHS). The study, its participants and their potential for genetic research on health and illness

CovidLife: a resource to understand mental health, well-being and behaviour during the COVID-19 pandemic in the UK

The PHQ-9: validity of a brief depression severity measure

Development and psychometric properties of the Emotional State Questionnaire, a self-report questionnaire for depression and anxiety

Screening for depression in primary care

Lö we B. A brief measure for assessing generalized anxiety disorder: the GAD-7

The dimensional obsessive-compulsive scale: development and validation of a short form (DOCS-SF)

The primary care PTSD screen for DSM-5 (PC-PTSD-5): development and evaluation within a veteran primary care sample

The PTSD Checklist (PCL): reliability, validity, and diagnostic utility

Perceived stress in a probability sample of the United States

Cross-cultural adaptation and validation of the Danish consensus version of the 10-item Perceived Stress Scale

Impact of Event Scale: a measure of subjective stress

A short scale for measuring loneliness in large surveys: results from two population-based studies

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

A new scale for measuring insomnia: the Bergen Insomnia Scale

Development of a fatigue scale

Assessing cognitive impairment using PROMIS V R applied cognition-abilities scales in a medical outpatient sample

Prevalence and variability of current depressive disorder in 27 European countries: a population-based study

Statistics Danmark. Folketal (Population). 2021

Statistics Iceland. Population by Sex and Age

Rahvastik aasta alguses ja aastakeskmine rahvaarv soo ja vanuse järgi (Population at the beginning of the year and mean annual population by sex and age)

Statistics Danmark. 2021. Befolkningens Højest Fuldførte Uddannelse

Educational Attainment of the Population by Levels According to ISCED

Vä hemalt 15 aastased hariduse, soo, vanusrü hma ja maakonna jä rgi, 1. jaanuar (At least 15-year-old persons by education, sex, age group and country

Population by Age and Sex. Year 1860-2020

Population, by Sex and One-Year Age Groups

Population 16-95þ Years of Age by Region, Level of Education

Scottish Council Area 2011 by Highest Level of Qualification by Term-Time Address (Indicator) and Age

A.M. has received speakers' fees from Illumina and Janssen and has received research grant funding from the Sackler Trust, outside of the current work. All other authors declare no conflict of interest.

Age (years) 18 

The